Skip to main content
. 2023 Nov 18;13:20213. doi: 10.1038/s41598-023-47611-w

Table 4.

Comparison of antibody presence in different COV2-vaccines.

Vaccine type Positive Result 1a (n = 462) P-value Positive Result 2b (n = 301) P-value
frequency percentage Chi-Square frequency Percentage Chi-Square
AstraZeneca 126 89.4  < 0.001 94 98.9 0.023
COVIran Barekat 97 62.6 94 89.5
Sinopharm 98 59.0 93 92.1

a:Antibody presence in participants’ sera after the first dose of COV2-vaccination, b: Antibody presence in participants’ sera one month after the second dose of COV2-vaccination.